EUVIMEDEUVIMED entdecken
Crossref

BRCA1 deficiency promotes DNA damage in cochlear hair cells with activation of ATM-p53 pathway independent of CHK2

Weitao Jiang, Feng Bai, Guanrun Wang, Xiong Liu, Bin Peng, Xingzhi Xu, Guohui Nie, Wei-Guo Zhu, Bing Hu, Xin-Hai Pei

Hearing Research · 2025

DOI: 10.1016/j.heares.2025.109369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hearing Research, 2025. Verfasst von Weitao Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: International Cancer Center, Marshall Laboratory of Biomedical Engineering, Department of Otolaryngology, The First Affiliated Hospital, Department o…. Hauptthemen laut MEDLINE: Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2, Tumor Suppressor Protein p53, BRCA1 Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Science, Technology and Innovation Commission of Shenzhen Municipality, Natural Science Foundation of Shenzhen Municipality, Shenzhen Science and Technology Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platinum-based chemotherapy drugs, including cisplatin (CDDP), are known to cause irreversible hearing loss. We recently discovered that BRCA1 facilitates the repair of CDDP-induced DNA double-strand breaks (DSBs) in cochlear hair cells (HCs) and prevents hearing loss. However, the checkpoint pathways activated in response to DSBs in HCs, and the mechanisms by which Brca1 regulates these pathways, remain unclear. In this study, we demonstrate that CDDP induces significant DSBs in outer HCs (OHCs), accompanied by phosphorylation of ATM, CHK2, and p53 at serine‑15 (S15) and S20, leading to apoptosis. In contrast, CDDP induces fewer DSBs in inner HCs (IHCs), with phosphorylation of ATM and p53 at S20, but not CHK2, promoting cell survival. Brca1 deficiency further increases phosphorylation of ATM and p53 at S15 in CDDP-treated OHCs. In response to CDDP, phosphorylation of CHK2 is not detected, but phosphorylation of p53 at S20 is enhanced in Brca1-deficient OHCs, whereas, phosphorylation of p53 at S20 is significantly increased in both Brca1-deficient and proficient IHCs. The expression patterns of phosphorylated ATM, CHK2, and p53 in response to CDDP in cultured explants and cell lines differ markedly from those observed in Brca1-deficient and proficient mice in vivo. These findings suggest that CDDP induces extensive DSBs in OHCs, activating the ATM-CHK2-p53 pathway to promote cell death, while Brca1 deficiency exacerbates CDDP-induced DSBs and activates ATM-p53 signaling independent of CHK2, accelerating OHC loss. Additionally, these results demonstrate that CDDP induces modest DSBs in IHCs with activation of the ATM-p53 pathway, independent of CHK2 and BRCA1, leading to cell survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ataxia Telangiectasia Mutated ProteinsCheckpoint Kinase 2Tumor Suppressor Protein p53BRCA1 ProteinDNA DamageHair Cells, Auditory, OuterHair Cells, AuditoryAnimalsCisplatinPhosphorylationSignal TransductionDNA Breaks, Double-StrandedApoptosisMice, KnockoutMiceMice, Inbred C57BLCell SurvivalAntineoplastic Agents

Stichwörter der Autor:innen

BRCA1Checkpoint pathwayCisplatinDNA damageHair cells

Substanzen

Ataxia Telangiectasia Mutated ProteinsCheckpoint Kinase 2Tumor Suppressor Protein p53BRCA1 ProteinCisplatinAtm protein, mouseChek2 protein, mouseTrp53 protein, mouseBrca1 protein, mouseAntineoplastic Agents

Autor:innen und Institutionen

  • International Cancer Center, Marshall Laboratory of Biomedical Engineering, Department of Otolaryngology, The First Affiliated Hospital, Department of Anatomy and Histology, Shenzhen University Medical School, Shenzhen…
  • Department of Pathology, Shenzhen University Medical School, Shenzhen 518060, China.
  • Guangdong Key Laboratory for Genome Stability & Disease Prevention and International Cancer Center, Shenzhen University Medical School, Shenzhen 518060, China.
  • Department of Otolaryngology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen 518035, China.
  • Department of Biochemistry and Molecular Biology, International Cancer Center, Shenzhen University Medical School, Shenzhen 518060, China.
  • Department of Otolaryngology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen 518035, China. Electronic address: szshent@email.szu.edu.cn.

Förderung

  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Natural Science Foundation of Shenzhen Municipality
  • Shenzhen Science and Technology Innovation Program
  • Shenzhen University
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Jiang, W., Bai, F., Wang, G., Liu, X., Peng, B., Xu, X., Nie, G., Zhu, W. G., Hu, B., & Pei, X. H. (2025). BRCA1 deficiency promotes DNA damage in cochlear hair cells with activation of ATM-p53 pathway independent of CHK2. Hearing Research. https://doi.org/10.1016/j.heares.2025.109369

Vancouver

Jiang W, Bai F, Wang G, Liu X, Peng B, Xu X, et al. BRCA1 deficiency promotes DNA damage in cochlear hair cells with activation of ATM-p53 pathway independent of CHK2. Hearing Research. 2025. doi:10.1016/j.heares.2025.109369

BibTeX
@article{Jiang2025,
  author = {Jiang, Weitao and Bai, Feng and Wang, Guanrun and Liu, Xiong and Peng, Bin and Xu, Xingzhi and Nie, Guohui and Zhu, Wei-Guo and Hu, Bing and Pei, Xin-Hai},
  title = {BRCA1 deficiency promotes DNA damage in cochlear hair cells with activation of ATM-p53 pathway independent of CHK2},
  journal = {Hearing Research},
  year = {2025},
  doi = {10.1016/j.heares.2025.109369}
}
Kostenlos starten →